The proposed transaction would lay the foundation for the development of new clinical programs and expanded services across the greater Philadelphia region, Penn Medicine said in a Jan. 11 news release. It would also build upon existing clinical integration in cancer care between the two systems.
Doylestown Hospital, the nonprofit system’s 247-bed, flagship facility, has been part of Penn Cancer Network for more than a decade. Penn Radiation Oncology at Doylestown, which provides care to more than 400 patients a year, opened in 2011.
“Our boards of trustees are excited about how this partnership with Penn Medicine will further expand Doylestown Health’s ability to deliver clinical excellence and positively impact the health and well-being of the communities we have faithfully served for more than 100 years,” President and CEO James Brexler said.
The health systems will work together over the next several months to reach a definitive agreement, which will then be subject to approval by federal and state regulators.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
